The Drug Enforcement Administration last week published an interim final rule expanding access to medication-assisted treatment under the SUPPORT for Patients and Communities Act of 2018.

Effective Oct. 30, the rule allows certain practitioners to treat more patients; permanently adds nurse practitioners and physician assistants to the definition of “qualifying other practitioner”; and permits practitioners to complete required opioid training in medical school or residency as well as post-residency.

DEA will accept comments on the rule through Jan. 4.

DEA also will accept comments through Jan. 4 on a proposed rule implementing requirements to report suspicious orders of controlled substances under the Preventing Drug Diversion Act of 2018. The rule would offer multiple options for reporting suspicious orders; establish a centralized database for reporting; define key terms; and require specific record-keeping practices.

Related News Articles

Headline
The AHA today submitted a letter to the Office of Science and Technology Policy in response to its request for information on regulatory reform for artificial…
Chairperson's File
Public
This week brings the fourth week of the federal government shutdown as Congress has yet to pass legislation to fund the government. This shutdown is a bit…
Headline
The government shutdown is expected to continue into next week as the Senate is expected to adjourn Oct. 23 with no plans to vote this weekend. The chamber Oct…
Headline
A report by the Department of Health and Human Services Office of the Inspector General found that many Medicare Advantage and Medicaid managed care plans…
Blog
Public
When a nonprofit hospital files the Internal Revenue Service (IRS) Form 990, Schedule H, it reports a wide range of activities and expenditures to demonstrate…
Headline
The Senate Oct. 16 failed for a 10th time to advance the continuing resolution to extend government funding and end the ongoing shutdown. The chamber adjourned…